» Articles » PMID: 23887938

CCAR1 Promotes Chromatin Loading of Androgen Receptor (AR) Transcription Complex by Stabilizing the Association Between AR and GATA2

Overview
Specialty Biochemistry
Date 2013 Jul 27
PMID 23887938
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Androgen receptor (AR), a ligand-dependent transcription factor, plays a critical role in prostate cancer onset and progression, and its transcriptional function is mediated largely by distinct nuclear receptor co-regulators. Here, we show that cell cycle and apoptosis regulator 1 (CCAR1) functions as an AR co-activator. CCAR1 interacted with and enhanced the transcriptional activity of AR. Depletion of CCAR1 caused reduction in androgen-dependent expression of a subset of AR target genes. We further showed that CCAR1 is required for recruitment of AR, MED1 and RNA polymerase II to the enhancers of AR target genes and for androgen-induced long-range prostate specific antigen enhancer-promoter interaction. The molecular mechanism underlying CCAR1 function in AR-mediated transcription involves CCAR1-mediated enhanced recruitment of GATA2, a pioneer factor for AR, to AR-binding sites. CCAR1 stabilized the interaction between AR and GATA2 by interacting directly with both proteins, thereby facilitating AR and GATA2 occupancy on the enhancers. Furthermore, CCAR1 depletion inhibited the growth, migration, invasion of prostate cancer cells and reduced the tumorigenicity of prostate cancer cells in vivo. Our results firmly established CCAR1 as an AR co-activator that plays a key role in AR transcription complex assembly and has an important physiological role in androgen signaling and prostate tumorigenesis.

Citing Articles

RUNX1-PDIA5 Axis Promotes Malignant Progression of Glioblastoma by Regulating CCAR1 Protein Expression.

Ji Q, Tu Z, Liu J, Zhou Z, Li F, Zhu X Int J Biol Sci. 2024; 20(11):4364-4381.

PMID: 39247813 PMC: 11379074. DOI: 10.7150/ijbs.92595.


Multifaceted roles of CCAR family proteins in the DNA damage response and cancer.

Lugano D, Barrett L, Westerheide S, Kee Y Exp Mol Med. 2024; 56(1):59-65.

PMID: 38172598 PMC: 10834508. DOI: 10.1038/s12276-023-01139-1.


m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.

Huang C, Xu R, Zhu X, Jiang H Cancer Gene Ther. 2023; 30(10):1426-1440.

PMID: 37563361 DOI: 10.1038/s41417-023-00650-x.


Long-range gene regulation in hormone-dependent cancer.

Tettey T, Rinaldi L, Hager G Nat Rev Cancer. 2023; 23(10):657-672.

PMID: 37537310 DOI: 10.1038/s41568-023-00603-4.


Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children.

Chang J, Lin L, Zhou C, Zhang X, Yang T, Wu H J Cell Mol Med. 2023; 27(15):2239-2248.

PMID: 37347215 PMC: 10399530. DOI: 10.1111/jcmm.17820.


References
1.
Bao B, Chuang B, Wang Q, Sartor O, Balk S, Brown M . Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate. 2008; 68(8):839-48. PMC: 2703184. DOI: 10.1002/pros.20749. View

2.
Heemers H, Tindall D . Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev. 2007; 28(7):778-808. DOI: 10.1210/er.2007-0019. View

3.
Zhou H, Yan J, Luo W, Ayala G, Lin S, Erdem H . SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005; 65(17):7976-83. DOI: 10.1158/0008-5472.CAN-04-4076. View

4.
Kang Z, Pirskanen A, Janne O, Palvimo J . Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem. 2002; 277(50):48366-71. DOI: 10.1074/jbc.M209074200. View

5.
Luo J, Yu Y, Cieply K, Lin F, Deflavia P, Dhir R . Gene expression analysis of prostate cancers. Mol Carcinog. 2002; 33(1):25-35. DOI: 10.1002/mc.10018. View